Speeding up early drug development
Drug aliquots for R&D
Therapeutic molecules of clinical-grade quality. From 1 mg. Ready to ship.
Therapeutic Molecules Biologics ADCs Monoclonal antibodies Bispecific antibodies Reference products
aliquoted from medicines
-
Which molecule(s)
are you looking for?
best selling products

Bevacizumab
H0403H07

Vedolizumab
12791714

Enfortumab Vedotin
3PA0185

Thyrotropin alfa
EY0190

Agalsidase beta
EW2122

Loncastuximab tesirine
S22E015C

Amivantamab
PES0C04

Enfortumab Vedotin
3PA0169

Teclistamab
AU1230P5

Rituximab
N7734B02
- Therapeutic drugs as aliquots
- Multiple drug batches
- Consumable, so no license needed
- Prompt Delivery
- Fraction of the original drug price
Filter our product list:
API
Antigen / Target
Therapeutic Areas
Therapeutic Indications
Classes of molecules
Isotypes
Expiry Date
CoA
Filters
Sort results
Reset
Apply
ProductBatch | Antigen | Molecular Class | Drug Brand | Quantity per vial | Expiry Date | Price | |
---|---|---|---|---|---|---|---|
TNF alpha |
Biosimilar , Monoclonal Antibody |
Amgevita® |
2 mg |
2021.12 |
304,00 € |
Max: 10
Min: 1
Step: 1
|
|
TNF alpha |
Monoclonal Antibody |
Humira® |
4 mg |
2026.02 |
451,00 € |
Max: 10
Min: 1
Step: 1
|
|
TNF alpha |
Biosimilar , Monoclonal Antibody |
Hulio® |
2 mg |
2023.02 |
304,00 € |
Max: 10
Min: 1
Step: 1
|
|
TNF alpha |
Biosimilar , Monoclonal Antibody |
Hukyndra® |
2 mg |
2023.10 |
354,00 € |
Max: 10
Min: 1
Step: 1
|
|
TNF alpha |
Biosimilar , Monoclonal Antibody |
Yuflyma® |
4 mg |
2024.02 |
354,00 € |
Max: 10
Min: 1
Step: 1
|
|
TNF alpha |
Monoclonal Antibody |
Humira® |
4 mg |
2025.05 |
451,00 € |
Max: 3
Min: 1
Step: 1
|
|
TNF alpha |
Monoclonal Antibody |
Humira® |
4 mg |
2018.12 |
451,00 € |
Max: 10
Min: 1
Step: 1
|
|
TNF alpha |
Monoclonal Antibody |
Humira® |
4 mg |
2019.03 |
451,00 € |
Max: 10
Min: 1
Step: 1
|
|
TNF alpha |
Monoclonal Antibody |
Humira® |
4 mg |
2019.03 |
451,00 € |
Max: 5
Min: 1
Step: 1
|
|
TNF alpha |
Monoclonal Antibody |
Humira® |
4 mg |
2019.07 |
451,00 € |
Max: 8
Min: 1
Step: 1
|
Evidentic – fast, accurate, secure
Our products are empowering researchers worldwide

"Overall, I'm very happy with my purchase from Evidentic, and I would highly recommend them to anyone looking for high-quality products with sustainable packaging."
Tara Foley
Senior Technical Officer | Dept of Anatomy and Neuroscience

"After having great difficulty sourcing therapeutic antibodies in the small quantities required for research purposes, Evidentic has been a revelation! I have found them to be very friendly and prompt in replying to orders and queries."
Dr. Cassey McRae
Senior R&D Scientist at Avacta Life Sciences

"Evidentic gives rapid access to originator biologics and different batches. For biosimilar developers and regulators, it will shorten the time to gauge the analytical acceptance range for multiple CQAs of biotherapeutics."
Prof. Dr. Henning von Horsten
Life Science Engineering, HTW Berlin

“Evidentic was the only source that offered small aliquots of original therapeutic mAbs at an affordable price range. The aliquots came in an easy-to-use-and-store format that was apt for my research purpose.”
Ivanna Hrynchak
PhD Student ICNAS, Universidade de Coimbra

“We develop innovative and biosimilar mAbs for a global market. Evidentic’s aRMPs are a great source of cost-efficient reference products for our research and development program.”
Tom H. Jin, M.D.
Director of Process Development

"Evidentic is a new source of cost-efficient therapeutic mAbs for our immonassays. And easy to order!”
Thibault Jonckheere
CEO

"Evidentic drug aliquots have helped us speed up our antibody characterization assays and selection of clonal cell lines. An easy and reliable source!"
Prof. (emeritus) Dr. Florian Wurm
CSO & Founder

”Evidentic can supply different batches of reference products for pre-clinical research. The quick access allows for ad-hoc ordering, keeps costs down and makes a headstart possible!”
Anjan Selz
Vice President Head of Biosimilars EMEA
Why buy aliquots?

Evidentic is a young innovative company providing original drugs for research and new drug development.
Through our unique concept, we enable our customers to buy small quantities of these drugs as consumables, saving costs and time.